Welcome to the UPF Digital Repository

Pharmacological treatment of asthma in a cohort of adults during a 20-year period: results from the European Community Respiratory Health Survey I, II and III

Show simple item record

dc.contributor.author Janson, Christer
dc.contributor.author García Aymerich, Judith
dc.contributor.author Jarvis, Deborah
dc.date.accessioned 2022-05-19T05:52:40Z
dc.date.available 2022-05-19T05:52:40Z
dc.date.issued 2019
dc.identifier.citation Janson C, Accordini S, Cazzoletti L, Cerveri I, Chanoine S, Corsico A et al. Pharmacological treatment of asthma in a cohort of adults during a 20-year period: results from the European Community Respiratory Health Survey I, II and III. ERJ Open Res. 2019 Feb 1;5(1):00073-2018. DOI: 10.1183/23120541.00073-2018
dc.identifier.issn 2312-0541
dc.identifier.uri http://hdl.handle.net/10230/53152
dc.description.abstract Asthma often remains uncontrolled, despite the fact that the pharmacological treatment has undergone large changes. We studied changes in the treatment of asthma over a 20-year period and identified factors associated with the regular use of inhaled corticosteroid (ICS) treatment. Changes in the use of medication were determined in 4617 randomly selected subjects, while changes in adults with persistent asthma were analysed in 369 participants. The study compares data from three surveys in 24 centres in 11 countries. The use of ICSs increased from 1.7% to 5.9% in the general population and the regular use of ICSs increased from 19% to 34% among persistent asthmatic subjects. The proportion of asthmatic subjects reporting asthma attacks in the last 12 months decreased, while the proportion that had seen a doctor in the last 12 months remained unchanged (42%). Subjects with asthma who had experienced attacks or had seen a doctor were more likely to use ICSs on a regular basis. Although ICS use has increased, only one-third of subjects with persistent asthma take ICSs on a regular basis. Less than half had seen a doctor during the last year. This indicates that underuse of ICSs and lack of regular healthcare contacts remains a problem in the management of asthma.
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher European Respiratory Society
dc.relation.ispartof ERJ Open Res. 2019 Feb 1;5(1):00073-2018
dc.rights © ERS 2019. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
dc.rights.uri https://creativecommons.org/licenses/by-nc/4.0/
dc.title Pharmacological treatment of asthma in a cohort of adults during a 20-year period: results from the European Community Respiratory Health Survey I, II and III
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.1183/23120541.00073-2018
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/publishedVersion

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics

Compliant to Partaking